Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 1/20 | 0.46 |
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 0.43 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CHKA | P35790 | 1/20 | 0.41 |
| ▸ | KIF11 | P52732 | 1/20 | 0.39 |
| ▸ | ABL1 | P00519 | 1/20 | 0.37 |
| ▸ | BCR | P11274 | 1/20 | 0.37 |
| ▸ | LOXL2 | Q9Y4K0 | 3/20 | 0.36 |
| ▸ | LOX | P28300 | 1/20 | 0.35 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.34 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.32 |
| ▸ | NOS3 | P29474 | 1/20 | 0.31 |
| ▸ | NOS2 | P35228 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29563920 | 1.00 | CYP19A1 (0.46) | CYP19A1TRPV4HSP90AA1CA2CHKA | |
| Hydrazine SCHEMBL4301523 | 0.95 | HSP90AA1 (0.44) | CYP19A1TRPV4HSP90AA1CA2CHKA | |
| Piperazine SCHEMBL4824527 | 0.88 | ADRB1 (0.46) | CYP19A1TRPV4HSP90AA1CA2CHKA | |
| Phenol SCHEMBL28808335 | 0.84 | CYP19A1 (0.44) | CYP19A1TRPV4HSP90AA1CA2CHKA | |
| Butyl Chloride SCHEMBL27454449 | 0.82 | CYP2D6 (0.40) | CYP19A1TRPV4HSP90AA1CA2CHKA | |
| SCHEMBL29628255 | 0.81 | CYP19A1 (0.43) | CYP19A1HSP90AA1CA2CHKAKIF11 | |
| SCHEMBL27581634 | 0.81 | CYP19A1 (0.47) | CYP19A1HSP90AA1CA2CHKAKIF11 | |
| SCHEMBL16454702 | 0.81 | CYP19A1 (0.43) | CYP19A1HSP90AA1CA2CHKAKIF11 | |
| SCHEMBL31691964 | 0.81 | CYP19A1 (0.43) | CYP19A1HSP90AA1CA2CHKAKIF11 | |
| SCHEMBL16454356 | 0.81 | CYP19A1 (0.43) | CYP19A1HSP90AA1CA2CHKAKIF11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 192 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4127157-B1 | MODIFIED DIPEPTIDE CLEAVASES, USES THEREOF AND RELATED KITS | ENCODIA INC (US) | 2026-02-11 | — | — | EP | claimed |
| CN-119630645-A | Flavivirus inhibitors | IRBM股份公司 | 2025-03-14 | — | — | CN | claimed |
| CN-118406090-A | Neutral triisocomplex iridium complex containing dithioformic acid derivative coordination, and preparation method and application thereof | 深圳信息职业技术学院 | 2024-07-30 | — | — | CN | claimed |
| CN-117165078-A | Cyanate resin with low dielectric loss suitable for winding forming process, preparation method and application | 中国科学院宁波材料技术与工程研究所 | 2023-12-05 | — | — | CN | claimed |
| EP-4013751-A1 | 2-HYDROXYCYCLOALKANE-1-CARBAMOYL DERIVATIVES | Idorsia Pharmaceuticals Ltd (CH) | 2022-06-22 | — | — | EP | claimed |
| CN-109400988-A | A kind of gasket seal and preparation method thereof | 慈溪市春潮密封件有限公司 | 2019-03-01 | — | — | CN | claimed |
| CN-105593215-B | 2, 4-or 4, 6-diaminopyrimidine compounds as IDH2 mutant inhibitors for the treatment of cancer | 安吉奥斯医药品有限公司 | 2019-01-15 | — | — | CN | claimed |
| CN-109195965-A | The inhibitor that WDR5 protein-protein combines | 普罗佩纶治疗公司 | 2019-01-11 | — | — | CN | claimed |
| CN-104093716-B | Biaryl ether sulfonamide compounds and its purposes as therapeutic agent | 克赛农制药股份有限公司 | 2017-06-23 | — | — | CN | claimed |
| CN-105906569-A | Preparation method of pyrimidine derivatives | 杰达维（上海）医药科技发展有限公司 | 2016-08-31 | — | — | CN | claimed |
| US-20140128373-A1 | COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR | PLEXXIKON INC. | 2014-05-08 | — | — | US | claimed |
| CN-103517710-A | Compounds and methods for kinase modulation, and indications therefor | PLEXXIKON INC | 2014-01-15 | — | — | CN | claimed |
| CN-102887860-A | Preparation method of 4-chloro-6-trifluoromethylpyrimidine type compound | SHANGHAI TITAN TECHNOLOGY CO LTD | 2013-01-23 | — | — | CN | claimed |
| CN-100338058-C | Novel indole derivatives | LANDBECK AS H (DK) | 2007-09-19 | — | — | CN | claimed |
| CN-1310909-C | Novel heteroaryl derivatives, their prepn. and use | LUNDBECK & CO AS H (DK) | 2007-04-18 | — | — | CN | claimed |
| CN-1529703-A | Novel indole derivatives | H��¡�±�������˾ | 2004-09-15 | — | — | CN | claimed |
| CN-1520410-A | Novel heteroaryl derivatives, their prepn. and use | H��¡�±�������˾ | 2004-08-11 | — | — | CN | claimed |
| CN-1255042-A | Diaryl ethers and processes for their preparation and herbicidal and desiccant compositions containing them | ISK AMERICAS INC (US) | 2000-05-31 | — | — | CN | claimed |
| EP-4743446-A1 | NITRO-CONTAINING COMPOUNDS THAT KILL MYCOBACTERIA | Board of Trustees of Michigan State University (US) | 2026-05-20 | — | — | EP | disclosed |
| US-4474599-A | 1-(Pyridyl)-1H-1,2,3-triazole derivatives, and use as herbicidal agents | THE DOW CHEMICAL COMPANY (US) | 1984-10-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140128373-A1 | COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR | MAP3K20, PRKACA, MAP3K13 | CYP19A1 3508/4885TRPV4 4326/4885HSP90AA1 583/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.